中文｜English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R
Volume 42 Issue 3
Mar.  2026
Turn off MathJax
Article Contents
Article Navigation >  Journal of Clinical Hepatology  > 2026  >  42(3): 586-592

Efficacy and safety of surgery-assisted transjugular intrahepatic portosystemic shunt in treatment of portal hypertension comorbid with complex portal vein thrombosis

DOI: 10.12449/JCH260313
  • 1.

    Department of Interventional Therapy，Beijing Shijitan Hospital，Capital Medical University，Beijing 100038，China

  • 2.

    Minimally Invasive Diagnosis and Treatment Center for Liver Diseases，Beijing Shijitan Hospital，Capital Medical University，Beijing 100038，China

  • 3.

    Department of General Surgery，Beijing Shijitan Hospital，Capital Medical University，Beijing 100038，China

Research funding:

Science and Technology Research and Development Program of China State Railway Group Co., Ltd (J2023Z609)

More Information
  • Corresponding author: WANG Lei， wanglei800212@126.com （ORCID： 0000-0002-4374-059X）
  • Received Date: 2025-06-10
  • Accepted Date: 2026-01-28
  • Published Date: 2026-03-25
    Abstract
  •   Objective  To investigate the feasibility， safety， and efficacy of surgery-assisted transjugular intrahepatic portosystemic shunt （SA-TIPS） in the treatment of portal hypertension comorbid with complex portal vein thrombosis， including cavernous transformation of the portal vein （CTPV）.  Methods  An analysis was performed for the data of 36 patients with portal hypertension and complex portal vein thrombosis who underwent SA-TIPS in Beijing Shijitan Hospital， Capital Medical University， from November 2023 to January 2025， including general status， technical data of the surgical process （surgical success rate， puncture times， time of operation， the number of stents used， and the length of shunt）， perioperative complications， and surgical recovery. The change in portal pressure gradient （PPG） after shunt was compared， and the rate of reaching the standard for PPG reduction was calculated， as well as stent patency rate within 1 week after surgery. The paired samples t-test was used for comparison of continuous data between two groups.  Results  Among the 36 patients， 34 （94.4%） underwent SA-TIPS successfully. The incidence rate of perioperative complications was 16.7% （6/36）， including 3 cases of thoraco-abdominal hemorrhage， 2 cases of intraoperative arrhythmia， and 1 case of incision infection. There was a significant reduction in PPG after SA-TIPS （t=19.85， P<0.01）， and the patients achieving a ≥50% reduction in PPG accounted for 76.5% （26/34）. Imaging reexamination within 1 week showed a shunt patency rate of 100%.  Conclusion  SA-TIPS has a high technical success rate， a favorable safety profile， and good efficacy in the treatment of portal hypertension comorbid with complex portal vein thrombosis （including CTPV）， and therefore， it holds promise for clinical application.

     

    • FullText(HTML)
  • loading
    • References(19)
  • [1]
    European Association for the Study of the Liver. EASL clinical practice guidelines on TIPS[J]. J Hepatol, 2025, 83( 1): 177- 210. DOI: 10.1016/j.jhep.2025.01.029.
    [2]
    The Chinese College of Interventionalists. CCI clinical practice guidelines: Management of TIPS for portal hypertension(2019 edition)[J]. J Clin Hepatol, 2019, 35( 12): 2694- 2699. DOI: 10.3969/j.issn.1001-5256.2019.12.010.

    中国医师协会介入医师分会. 中国门静脉高压经颈静脉肝内门体分流术临床实践指南(2019年版)[J]. 临床肝胆病杂志, 2019, 35( 12): 2694- 2699. DOI: 10.3969/j.issn.1001-5256.2019.12.010.
    [3]
    ZHANG JB, CHEN J, ZHOU J, et al. Systematic review and meta-analysis of trans-jugular intrahepatic portosystemic shunt for cirrhotic patients with portal vein thrombosis[J]. World J Clin Cases, 2021, 9( 19): 5179- 5190. DOI: 10.12998/wjcc.v9.i19.5179.
    [4]
    RODRIGUES SG, SIXT S, ABRALDES JG, et al. Systematic review with meta-analysis: Portal vein recanalisation and transjugular intrahepatic portosystemic shunt for portal vein thrombosis[J]. Aliment Pharmacol Ther, 2019, 49( 1): 20- 30. DOI: 10.1111/apt.15044.
    [5]
    VALENTIN N, KORRAPATI P, CONSTANTINO J, et al. The role of transjugular intrahepatic portosystemic shunt in the management of portal vein thrombosis: A systematic review and meta-analysis[J]. Eur J Gastroenterol Hepatol, 2018, 30( 10): 1187- 1193. DOI: 10.1097/MEG.0000000000001219.
    [6]
    GUO DF, FAN LW, LE Q, et al. Transjugular intrahepatic portosystemic shunt for the prevention of rebleeding in patients with cirrhosis and portal vein thrombosis: Systematic review and meta-analysis[J]. Front Pharmacol, 2022, 13: 968988. DOI: 10.3389/fphar.2022.968988.
    [7]
    ZHU KS, MENG XC, ZHOU B, et al. Percutaneous transsplenic portal vein catheterization: Technical procedures, safety, and clinical applications[J]. J Vasc Interv Radiol, 2013, 24( 4): 518- 527. DOI: 10.1016/j.jvir.2012.12.028.
    [8]
    SALEM R, VOUCHE M, BAKER T, et al. Pretransplant portal vein recanalization-transjugular intrahepatic portosystemic shunt in patients with complete obliterative portal vein thrombosis[J]. Transplantation, 2015, 99( 11): 2347- 2355. DOI: 10.1097/TP.0000000000000729.
    [9]
    LI WX, CUI MZ, LI Q, et al. Application of transmesenteric vein extrahepatic portosystemic shunt in treatment of symptomatic portal hypertension with cavernous transformation of portal vein[J]. J Interv Med, 2023, 6( 2): 90- 95. DOI: 10.1016/j.jimed.2023.04.001.
    [10]
    JALAEIAN H, TALAIE R, D’SOUZA D, et al. Minilaparotomy-assisted transmesenteric-transjugular intrahepatic portosystemic shunt: Comparison with conventional transjugular approach[J]. Cardiovasc Intervent Radiol, 2016, 39( 10): 1413- 1419. DOI: 10.1007/s00270-016-1385-3.
    [11]
    LI HJ, YIN FQ, MA YT, et al. Administration of anticoagulation strategies for portal vein thrombosis in cirrhosis: Network meta-analysis[J]. Front Pharmacol, 2025, 15: 1462338. DOI: 10.3389/fphar.2024.1462338.
    [12]
    ZHU JY, XIA YF, LIU X, et al. Preventing variceal rebleeding in cirrhotic patients with portal vein thrombosis: A systematic review and meta-analysis[J]. J Gastroenterol Hepatol, 2024, 39( 4): 642- 648. DOI: 10.1111/jgh.16489.
    [13]
    SUN GL, WANG JY, ZHANG BN, et al. Case report: Management of liver cancer complicated by gastric varices rupture and bleeding: Transjugular intrahepatic portosystemic shunt utilizing the mesenteric venous pathway[J]. Front Med, 2024, 11: 1388584. DOI: 10.3389/fmed.2024.1388584.
    [14]
    PELIZZO G, QUARETTI P, MORAMARCO LP, et al. One step minilaparotomy-assisted transmesenteric portal vein recanalization combined with transjugular intrahepatic portosystemic shunt placement: A novel surgical proposal in pediatrics[J]. World J Gastroenterol, 2017, 23( 15): 2811- 2818. DOI: 10.3748/wjg.v23.i15.2811.
    [15]
    DAVIS JPE, LIM JK, FRANCIS FF, et al. AGA clinical practice update on management of portal vein thrombosis in patients with cirrhosis: Expert review[J]. Gastroenterology, 2025, 168( 2): 396- 404. DOI: 10.1053/j.gastro.2024.10.038.
    [16]
    LYU Y, FAN DM, HAN GH. Application status and future prospect of transjugular intrahepatic portosystemic shunt in gastroesophageal variceal bleeding in liver cirrhosis[J]. J Clin Hepatol, 2022, 38( 6): 1229- 1233. DOI: 10.3969/j.issn.1001-5256.2022.06.004.

    吕勇, 樊代明, 韩国宏. 经颈静脉肝内门体分流术在肝硬化食管胃底静脉曲张破裂出血中的应用现状与未来展望[J]. 临床肝胆病杂志, 2022, 38( 6): 1229- 1233. DOI: 10.3969/j.issn.1001-5256.2022.06.004.
    [17]
    LI TQ, LIU JC, ZHOU C, et al. The auxiliary target means used for improving the success rate of TIPS in treating portal vein occlusion[J]. J Interv Radiol, 2022, 31( 8): 805- 809. DOI: 10.3969/j.issn.1008-794X.2022.08.014.

    李铜强, 刘家成, 周晨, 等. 提高经颈静脉肝内门体分流术治疗门静脉闭塞技术成功率的辅助靶标手段[J]. 介入放射学杂志, 2022, 31( 8): 805- 809. DOI: 10.3969/j.issn.1008-794X.2022.08.014.
    [18]
    Hepatobiliary Disease Study Group, Chinese Society of Gastroenterology, Chinese Medical Association. Consensus for management of portal vein thrombosis in liver cirrhosis(2020, Shanghai)[J]. J Clin Hepatol, 2020, 36( 12): 2667- 2674. DOI: 10.3969/j.issn.1001-5256.2020.12.007.

    中华医学会消化病学分会肝胆疾病学组. 肝硬化门静脉血栓管理专家共识(2020年, 上海)[J]. 临床肝胆病杂志, 2020, 36( 12): 2667- 2674. DOI: 10.3969/j.issn.1001-5256.2020.12.007.
    [19]
    GIRI S, SINGH A, DAS S, et al. Efficacy and safety of transjugular intrahepatic portosystemic shunt in patients with hepatocellular carcinoma-a systematic review and meta-analysis[J]. Indian J Gastroenterol, 2024, 43( 6): 1121- 1135. DOI: 10.1007/s12664-024-01646-7.
    • Relative Articles
    • Supplements(0)
    • Cited By
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Figures(4)  / Tables(3)

    Get Citation
    PDF
    XML

    Article Metrics

    Article views (33) PDF downloads(9) Cited by()
    Proportional views
    Related
        

    The first journal specializing in hepatobiliary and pancreatic diseases in China

    Supervisor：Ministry of Education of the People's Republic of China

    Sponsor：Jilin University

    Academic Support: Chinese Society of Hepatology，Chinese Medical Association

    Address: 461 Xinjiang Road, Changchun

    Submit：0431-88782044

    Peer review：0431-88783542

    Email：lcgdb@vip.163.com

    About Journal

    Submission Guideline

    Journal Online

    Hepatobiliary College

    Guidelines

    YesterdayIP[]YesterdayPV[]TodayIP[]TodayPV[]Online[]

    Website Design © 2020 Editorial Board of Journal of Clinical Hepatology 吉ICP备10000617号-1 Supported by: Beijing Renhe Information Technology Co. Ltd  

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return